| dc.contributor.author |
Gazouli, M |
en |
| dc.contributor.author |
Tzanakis, N |
en |
| dc.contributor.author |
Rallis, G |
en |
| dc.contributor.author |
Theodoropoulos, G |
en |
| dc.contributor.author |
Papaconstantinou, I |
en |
| dc.contributor.author |
Kostakis, A |
en |
| dc.contributor.author |
Anagnou, N |
en |
| dc.contributor.author |
Nikiteas, N |
en |
| dc.date.accessioned |
2014-06-06T06:49:09Z |
|
| dc.date.available |
2014-06-06T06:49:09Z |
|
| dc.date.issued |
2009 |
en |
| dc.identifier.uri |
http://dx.doi.org/10.1007/s00384-008-0601-2 |
en |
| dc.identifier.uri |
http://62.217.125.90/xmlui/handle/123456789/4464 |
|
| dc.subject |
Cell Cycle Regulation |
en |
| dc.subject |
Colorectal Cancer |
en |
| dc.subject |
Healthy Subjects |
en |
| dc.subject |
Messenger Rna |
en |
| dc.subject |
Mrna Expression |
en |
| dc.subject |
Polymerase Chain Reaction |
en |
| dc.subject |
Polymorphism |
en |
| dc.subject |
Restriction Fragment Length Polymorphism |
en |
| dc.subject |
Reverse Transcriptase |
en |
| dc.subject |
C Promoter |
en |
| dc.subject |
Risk Factors |
en |
| dc.title |
Survivin -31G/C promoter polymorphism and sporadic colorectal cancer |
en |
| heal.type |
journalArticle |
en |
| heal.identifier.primary |
10.1007/s00384-008-0601-2 |
en |
| heal.publicationDate |
2009 |
en |
| heal.abstract |
Introduction Survivin is an apoptotic inhibitor, plays an important role in cell cycle regulation, and may be involved in the development and progression of cancer. A common polymorphism at the survivin gene promoter (-31 G/C) has been shown to influence survivin expression and the risk for cancer. Aim The aim of the present study was to investigate whether this polymorphism could be |
en |
| heal.journalName |
International Journal of Colorectal Disease |
en |
| dc.identifier.doi |
10.1007/s00384-008-0601-2 |
en |